Last Updated:
Name Designation Appointment Date Status
Roshnil Manish Rajeshirke

Appointed as Designated Partner since December 2024

 Designated Partner 27-Dec-2024 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Celchem.Pharmaceuticals Llp.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Sanjay Sharma

Appointed as Designated Partner since December 2024

 Designated Partner 27-Dec-2024 Current
Umesh Kumar

Appointed as Designated Partner since December 2024

 Designated Partner 27-Dec-2024 Current

People Timeline

Explore the timeline of key personnel in Celchem.Pharmaceuticals Llp's leadership journey.

Contact Details
  • Address Suraj Chs Shop No 12 Building No 1 C Wing Ambarnath Thane, Sarvoday Nagar Badlapur West, Ambarnath Maharashtra, 421503, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 421503
  • Country India
  • Website -
Frequently Asked Questions
You can contact Celchem.Pharmaceuticals Llp through their registered address at Suraj Chs Shop No 12 Building No 1 C Wing Ambarnath Thane, Sarvoday Nagar Badlapur West, Ambarnath Maharashtra, 421503, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Celchem.Pharmaceuticals Llp are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ROSHNIL MANISH RAJESHIRKE
  • Sanjay Sharma
  • Umesh Kumar
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available